The Health Care M&A Monthly: Novartis Offers to Buy Rest of Chiron Corp. for $4.5 Billion
Influenza pandemics have been traveling the world long before globalization spread business and industry over the face of the earth. Western Europe is currently worried by the possibility of avian flu reaching it from Southeast Asia. And, as autumn approaches, we are...The Health Care M&A Monthly: Teva Stays on Top of Generics With $8 Billion Purchase of Ivax
Rapid consolidation among generic pharmaceutical companies is continuing through the sweltering days of the summer. Last month’s issue reported that Teva Pharmaceuticals (NASDAQ: TEVA) was on the prowl for an acquisition that would make it once again the largest...The Health Care M&A Monthly: UnitedHealth Group Offers $9.2 Billion to Buy PacifiCare
To become the country’s largest manager of Medicare plans and grow its West Coast business, UnitedHealth Group (NYSE: UNH) is acquiring PacifiCare Health Systems (NYSE: PHS). In consummating what is the second-largest managed care deal ever nnounced, UnitedHealth will...The Health Care M&A Monthly: Pfizer Props Its Pipeline With A $1.9 Billion Deal
Often as not, the names given to federal legislation disguise, rather than describe, the content of the bill. And, no, we’re not talking about the Patriot Act. What we have in mind is the American Jobs Creation Act of 2004 (AJCA). A close reading of this law reveals...The Health Care M&A Monthly: Fresenius Clinches $4 Billion Deal To Buy Renal Care Group
One big deal can easily beget an-other. When a merger between two companies threatens to displace a third company from an advantageous market position, we often see the affected company pursue its own deal to regain and shore up its cherished position. This gambit is...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
